Lexapro®‘s Efficacy After Dose Escalation in Remission Study
Condition(s):Major Depressive DisorderLast Updated:September 7, 2018Completed
Hide Studies Not Open or Pending
Condition(s):Major Depressive DisorderLast Updated:September 7, 2018Completed
Condition(s):AnxietyLast Updated:November 6, 2020Completed
Condition(s):Major Depressive DisorderLast Updated:June 24, 2015Completed
Condition(s):AnxietyLast Updated:September 14, 2023Recruiting
Condition(s):Alcohol DependenceLast Updated:July 23, 2019Completed
Condition(s):Irritable Bowel Syndrome; Panic DisorderLast Updated:January 12, 2017Completed
Condition(s):Chronic Posttraumatic Stress DisorderLast Updated:December 2, 2009Completed
Condition(s):Major Depressive Disorder, Bipolar I and Bipolar IILast Updated:March 21, 2018Completed
Condition(s):Obesity, MorbidLast Updated:March 27, 2023Recruiting
Condition(s):Anorexia NervosaLast Updated:April 3, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.